Key result
In STEMI patients, a CHA2DS2-VASc score ≥ 4 predicted a high syntax score, and patients without atrial fibrillation had a higher average ejection fraction than those with it.
Why the study?
The study was conducted to evaluate the potential usefulness of the CHA2DS2-VASc score as a predictor of short-term complications in STEMI patients without atrial fibrillation.
Does the CHA2DS2-VASc score predict high SYNTAX score and short-term complications in STEMI patients without atrial fibrillation?
Cohort (n=80)
No
Does the CHA2DS2-VASc score predict high SYNTAX score and short-term complications in STEMI patients without atrial fibrillation?
The CHA2DS2-VASc score may serve as a useful predictor of coronary anatomic complexity (high SYNTAX score) in STEMI patients, even in the absence of atrial fibrillation.
Answers are grounded in this paper and cite their sources.
May aid anatomic risk stratification in STEMI without AF; hypothesis-generating and should not yet change practice.
Background: ST elevation myocardial infarction (STEMI) is a clinical syndrome defined by characteristic symptoms of myocardial ischemia accompanied by persistent elevation the ST segment on electrocardiograph (ECG) and subsequent release of biomarkers of myocardial necrosis. Objective: The aim of the study was to evaluate the possibility of usefulness of CHA2DS2 -VASc Score as a predictor of short-term complications in STEMI patients without atrial fibrillation. Patients and methods: This prospective cohort study was carried out on 80 STEMI patients who presented to the Coronary Care Unit (CCU), Zagazig University Hospital, during the period from December 2021 to June 2022. They were divided into two equal groups: Group (A); STEMI without AF, included 40 patients, 31 (77.5%) males and 9 (22.5%) females whose age ranged from 35 to 75 years. Group (B); STEMI with AF, included 40 patients, 28 (70%) males and 12 (30%) females whose age ranged from 42 to 78 years. CHA2DS2- VASc Score, and syntax score were calculated for each patient. Results: The average EF% among STEMI patients without AF was higher than STEMI patients with AF (53.5 ± 7.5> 49.4 ± 10.5) ranged from (36 to 66) and from (33 to 68) respectively, this difference was statistically significant (p-value=<0.04*). CHA2DS2-VASC score with cutoff value ≥ 4 was very good predictor for high syntax score in both groups. Conclusion: It could be concluded that CHA2DS2-VASc score could be applied to predict the risk of subsequent thromboembolic events in patient with atrial fibrillation. This score has represented ample power in estimating major adverse cardiovascular outcomes in the sitting of acute coronary syndrome.
No takes yet. Share an insight, caveat, or question.
Shereef et al. (2022) conducted a cohort in ST elevation myocardial infarction (STEMI) (n=80). CHA2DS2-VASc Score was evaluated on Average Ejection Fraction (EF%) (p=<0.04). In STEMI patients, a CHA2DS2-VASc score ≥ 4 predicted a high syntax score, and patients without atrial fibrillation had a higher average ejection fraction than those with it.
Synapse has enriched 10 related papers. Consider them for comparative context: